Skip to main content

Table 4 Results of the multivariate analysis of the predictors in relation to OTC-medication use during pregnancy

From: Prevalence and predictors of over-the-counter medication use among pregnant women: a cross-sectional study in the Netherlands

Predictor

B (regression coefficient)

Significance

OR (95%CI)*

Prescription drugs†

0.418

0.101

1.52 (0.92-2.50)

Nulliparity‡

0.472

0.009

1.60 (1.12-2.29)

Comorbidity±

0.887

0.000

2.43 (1.53-3.87)

Body Mass Index (kg/m2) ≠

0.483

0.022

1.62 (1.07-2.46)

1 General Practitioner visit T

0.224

0.321

1.25 (0.80-1.95)

2 General Practitioner visits T

0.507

0.063

1.66 (0.97-2.83)

≥3 General Practitioner visits T

0.684

0.028

1.98 (1.07-3.65)

  1. *Odds Ratio and the 95% confidential intervals.
  2. † No use of prescription drugs is the reference category.
  3. ‡ Never been pregnant (nulliparity) is the reference category.
  4. ± No comorbidities is the reference category.
  5. ≠A BMI of <26 >30 kg/m2 is the reference category.
  6. T No extra visits to the GP is the reference category.